• Cue Health Makes De Novo Submission to FDA for Full Clearance of Its Molecular COVID-19 Test

    25 days ago - By San Diego Biotechnology

    SAN DIEGO, May 2, 2022 /PRNewswire/ - Cue Health today became the first company to submit to the U.S. Food and Drug Administration for full clearance of its molecular COVID-19 test...
    Read more ...

     

  • Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

    26 days ago - By San Diego Biotechnology

    Viral capture efficiency ranged from 53% to 89% for the seven COVID-19 variants tested SAN DIEGO, May 2, 2022 /PRNewswire/ - Aethlon Medical, Inc. , a medical technology company focused on developing products to...
    Read more ...